Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
02/2009
02/11/2009CN100460400C Continuous production process of high purity trimellitic anhydride with trimellitic acid
02/10/2009US7488836 treating autoimmune disease, cancer, or atherosclerosis; inhibiting TNF alpha expression, IL-1 beta expression, iNOS expression, and NF- kappa B activity; (3aR,6Z,10E,11aR)-10-methyl-3-methylene-2-oxo-2,3,3a,4,5,8,9,11a-octahydrocyclodeca[b]furan-6-carboxylic acid
02/10/2009US7488752 Thrombin receptor antagonists
02/10/2009CA2336691C Ligands for metals and metal-catalyzed processes
02/10/2009CA2292226C Chlorhexidine formulations, new chlorhexidine salts, solutions containing these and their use
02/05/2009WO2009016964A1 Light-emitting device material and light-emitting device
02/05/2009WO2009016565A1 Tricyclic compounds for the treatment of inflammatory disorders
02/05/2009WO2009016375A2 Polyglycerol ethers of sorbitan carboxylic acid esters
02/05/2009WO2009016220A1 Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives
02/05/2009WO2009016218A2 Fungicide n-cycloalkyl-n-bicyclic-carboxamide derivatives
02/05/2009WO2009015801A1 Oxaspirocyclic spiro-substituted tetramic and tetronic acid derivatives
02/05/2009WO2009015407A1 Method of preparing naphthalocyanines
02/05/2009US20090036692 Process for Production of Substituted Cyclopentanone
02/05/2009US20090036521 Process for Production of Optically Active Amine Derivatives
02/05/2009US20090036501 2-Cyclopenten-1-One Oxime Derivatives Inhibiting Production of TNF-Alpha
02/05/2009US20090036492 Novel Cercosporamide Derivative
02/05/2009US20090036439 5-[(3',5'-dichloro-1,1'-biphenyl-3-yl)methylene]-3-(3,5-dichlorophenyl)-4-hydroxyfuran-2(5H)-one; bacterial cell wall biosynthesis via the Mur enzyme pathway; bactericides; paraciticides; nematocides; antibiotic-resistant diseases; agiculture; veterinary medicine
02/05/2009US20090036423 Immunosuppresant compounds and compositions
02/05/2009US20090036420 Benzamide derivatives and their use for treating cns disorders
02/05/2009US20090033210 Compound and organic light emitting device
02/05/2009DE19881631B4 Verfahren zur Reinigung von Tetrahydrofuranen, die als Ausgangsmaterial für Polyetherpolyole verwendet werden A process for purifying tetrahydrofurans, which are used as starting material for polyether polyols
02/05/2009CA2695032A1 Oxaspirocyclic spiro-substituted tetramic and tetronic acid derivatives
02/05/2009CA2692767A1 Fungicidal n-cycloalkyl-benzyl-thiocarboxamides or n-cycloalkyl-benzyl-n' -substituted-amidine derivatives
02/05/2009CA2687907A1 Method of preparing naphthalocyanines
02/04/2009EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
02/04/2009CN101360731A Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins
02/04/2009CN101360730A Fungicide N-cycloalkyl-benzyl-amide derivatives
02/04/2009CN101357911A Method for synthesizing (z)-2-(alpha-methoxyimino)furan-ammonium acetate
02/04/2009CN101357910A Method for synthesizing 2-acetylfuran
02/04/2009CN100457757C Novel spiro compounds
02/04/2009CN100457747C Preparation process of key intermediate 5-cyanphthalide of antidepressant drug citalopram
02/04/2009CN100457746C Method for the preparation of escitalopram
02/04/2009CN100457745C Synthetic process for 2-butyl-3(hydroxy 3,5-diiodo-benzoyl) benzofuran
02/04/2009CN100457726C Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes
02/03/2009CA2382435C Novel herbicidally active phenyl-substituted heterocycles
02/03/2009CA2352786C Benzofuran derivatives, process for the preparation of the same and uses thereof
02/03/2009CA2259936C Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
01/2009
01/29/2009WO2009015369A2 Isophthalamide derivatives inhibiting beta-secretase activity
01/29/2009WO2009014550A1 System for controlling the reactivity of boronic acids
01/29/2009WO2009014343A2 Ascorbic acid derivatives having alpha-lipoyl groups and process for preparing the same
01/29/2009WO2009013195A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
01/29/2009WO2008116339A3 Organic compounds
01/29/2009WO2007144769A8 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
01/29/2009US20090030215 Method for production of 5-hydroxymethyl-2-furfural from fructose
01/29/2009US20090030214 Oxidation Process
01/29/2009US20090030213 Stabalized Vegetable Oils And Methods Of Making Same
01/29/2009US20090030051 Inhibitors of IMPDH enzyme
01/29/2009US20090029991 Benzamide derivatives useful as histone deacetylase inhibitors
01/29/2009US20090029947 Sphingosine-1-phosphate receptor agonist and antagonist compounds
01/29/2009US20090029858 Spirocyclic 3'-Alkoxytetramic Acids and -Tetronic Acids
01/29/2009US20090029290 Tertiary alcohol derivative, polymer compound and photoresist composition
01/29/2009US20090028804 AhR mediators
01/29/2009CA2697166A1 Isophthalamide derivatives inhibiting betasecretase activity
01/29/2009CA2694224A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
01/29/2009CA2694068A1 System for controlling the reactivity of boronic acids
01/29/2009CA2693207A1 Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
01/28/2009EP2018364A1 Therapeutic fluoroethyl ureas
01/28/2009EP0966443B1 Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
01/28/2009CN101356166A Method for preparing 3-hydroxyl tetrahydrofuran using cyclodehydration
01/28/2009CN101356165A Process for preparing gemcitabine and associated intermediates
01/28/2009CN101356155A Phenoxy acetic acids as PPAR-delta activators
01/28/2009CN101353337A Vitamin C clean production method
01/28/2009CN101353336A Method and system for preparing furfuryl alcohol by furfural liquid phase hydrogenation
01/28/2009CN101353335A Method for preparing furfuryl alcohol by furfural medium-pressure continuous liquid phase hydrogenation and hydrogenation reactor thereof
01/28/2009CN101353324A Synthesis of enantiomerically pure amino-substituted fused bicyclic rings
01/28/2009CN100455566C Novel derivatives of aminocyclohexane
01/27/2009US7482477 cyclization of the precursor diol in the presence of an azodicarboxylate, a phosphine and a strong base; diol is 4-(4-dimethylamino)-1-(4'-fluorophenyl)-1-(hydroxybutyl)-3-(hydroxymethyl)benzonitrile; safer, stable reactants, reproducable on an industrial scale, nonracemizing
01/27/2009US7482476 reaction with thionyl chloride to form 5-chlorocarbonyl phthalide intermediate which is reacted with hydroxylamine and then dehydrated; one pot process; intermediate is not isolated; no dangerous reagents; product is intermediate for Citalopram
01/27/2009US7482466 Hydroxamates as therapeutic agents
01/27/2009US7482449 Combining strong base with phenyl isonicotinamide in aprotic solvents to form solution, then reacting with cyclohexanone carboxylic acid or ester and water, and acidifying the solution to obtain chemical intermediates for neuropeptide Y antagonists used for treating bulimia, obesity or diabetes
01/27/2009US7482437 Protease inhibitor conjugates and antibodies useful in immunoassay
01/27/2009US7482368 Triamide-substituted heterobicyclic compounds
01/27/2009CA2346796C Benzoylcyclohexanediones, process for their preparation and their use as herbicides and plant growth regulators
01/27/2009CA2294586C Homoserine lactones biofilm regulating compounds and their methods of use
01/27/2009CA2290520C Inhibition of p38 kinase activity by aryl ureas
01/27/2009CA2206238C Alkylidenehydrazinophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
01/22/2009WO2009012445A1 Method for production of 5-hydroxymethyl-2-furfural from fructose
01/22/2009WO2009010503A1 Mycophenolic acid recycling in a method for the preparation of mycophenolate mofetil
01/22/2009WO2009010454A2 Amido derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors
01/22/2009WO2008129189A3 Novel carbamate compounds of vitamin c, compositions comprising the same, and uses thereof
01/22/2009WO2008125616A3 Method for the purification of bio-molecules
01/22/2009US20090023923 1-(4-Bromo-3-methyphenyl)-3-(3,5-dichlorophenyl)-3-hydroxy-4,4,4-trifluorobutane-1-one; -(4-Bromo-3-methylphenyl)-3-(3,5-dichlorophenyl)-4,4,4-trifluoro-2-butene-1-one; chemical intermediates for agricultural pesticides, insecticides
01/22/2009US20090023918 Process for preparing 3-acylaminobenzofuran-2-carboxylic acid derivative
01/22/2009US20090023878 (Meth)acrylate derivative, polymer and photoresist composition having lactone structure, and method for forming pattern by using it
01/22/2009US20090023800 Cannabinoid receptor modulator
01/22/2009US20090023798 Thiohydroxamates as inhibitors of histone deacetylase
01/22/2009US20090023783 (2,4-Dichloro-phenyl)-(3-methyl-6-m-tolyl-benzofuran-2-yl)-methanone; anticarcinogenic, antiproliferative, antitumor agent; solid tumor, metastasis, lymphomas, leukemia; Cell Titre-Glo/High Throughput Assay
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009US20090023664 protease inhibitors such as 5-(dimethylamino)-N-[(2S,3R)-3-hydroxy-4-[(4-methoxyphenyl)sulfonyl-(2-methylpropyl)amino]-1-phenylbutan-2-yl]-2-methylbenzamide, used for for treating human immunodeficiency virus (HIV) infections
01/21/2009EP2017271A1 Process for the preparation of escitalopram
01/21/2009EP2016057A1 C-fms kinase inhibitors
01/21/2009EP2015647A2 Iron complex for use in the treatment and/or prevention of nutritional disorders
01/21/2009EP1501791B1 Amino acid analogues
01/21/2009EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
01/21/2009CN101348474A Method for preparing salvianolic acid B and tanshinol from Salvia miltiorrhiza stem
01/21/2009CN101348460A Substituted furan (pyridine, pyrazole) formamide tertiary butyl thiacetic mulin ester
01/21/2009CN101347534A Effective component of gamene and preparation and use thereof
01/21/2009CN101347518A Effective component of red paeonia and preparation and use thereof
01/21/2009CN101347504A Effective component of salvia root and preparation thereof and use
01/21/2009CN101347484A Effective component of Atractylodes macrocephala and preparation and use thereof